New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia
Banaszkiewicz, M.; Małyszko, J.; Vesole, D.H.; Woziwodzka, K.; Jurczyszyn, A.; Żórawski, M.; Krzanowski, M.; Małyszko, J.; Batko, K.; Kuźniewski, M.; Krzanowska, K. New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia. J. Clin. Med. 2019, 8, 1828. https://doi.org/10.3390/jcm8111828
Banaszkiewicz M, Małyszko J, Vesole DH, Woziwodzka K, Jurczyszyn A, Żórawski M, Krzanowski M, Małyszko J, Batko K, Kuźniewski M, Krzanowska K. New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia. Journal of Clinical Medicine. 2019; 8(11):1828. https://doi.org/10.3390/jcm8111828
Chicago/Turabian StyleBanaszkiewicz, Małgorzata, Jolanta Małyszko, David H. Vesole, Karolina Woziwodzka, Artur Jurczyszyn, Marcin Żórawski, Marcin Krzanowski, Jacek Małyszko, Krzysztof Batko, Marek Kuźniewski, and Katarzyna Krzanowska. 2019. "New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia" Journal of Clinical Medicine 8, no. 11: 1828. https://doi.org/10.3390/jcm8111828